MegaDerm Plus
MarketedAcellular dermal matrix approved for import and sale in China, with an application filed for local production.
FROM PUBLIC EVENTS · 2026-11-15
Global approvals · expansion Undergoing review to produce its tissue grafts locally at its Kunshan plant in China. Also seen: Late clinical · capacity
Roles often seen at this stageRegulatory affairs · Manufacturing & MSAT · Sales & marketing
A maker of human-tissue grafts such as acellular dermal matrix and aesthetic products, preparing local production at its Kunshan plant in China.
Acellular dermal matrix approved for import and sale in China, with an application filed for local production.
Its Chinese subsidiary applied for approval to produce MegaDerm Plus locally.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.